In the media

17 Oct 2024

¿Dónde están los fondos para las enfermedades que atacan a mil millones de pobres?

El País

In the media

14 Oct 2024

Black fever, brought to you by climate change

The Xylom

News

10 Oct 2024

Nobel prize for chemistry awarded to Demis Hassabis and John Jumper for AlphaFold, an AI model used by DNDi for neglected diseases

Scientific articles

8 Oct 2024

Discovery of a series of macrocycles as potent inhibitors of Leishmania Infantum

Journal of Medicinal Chemistry

Viewpoints

7 Oct 2024

On World Meningitis Day, too many people are dying of cryptococcal meningitis in Africa

African Arguments

In the media

7 Oct 2024

New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine

The Lancet Infectious Diseases

News

4 Oct 2024

DNDi media fellowship for Eastern African health journalists

News

4 Oct 2024

DNDi 2024 Projects of the Year recognize contributions of DNDi teams and partners working to deliver medical innovations for people affected by leishmaniasis and sleeping sickness

In the media

3 Oct 2024

Loiasis: bringing an end to neglect

The Lancet

Stories

1 Oct 2024

Drug discovery explained: What are host-directed therapies?

Scientific articles

25 Sep 2024

The promise of health for all: a collaborative model to close treatment gaps for neglected diseases

Clinical Pharmacology and Therapeutics

Publications

24 Sep 2024

HAT Platform Newsletter No. 23

Publications

19 Sep 2024

InfoLEISH 8^th edition

Publications

19 Sep 2024

Chagas Platform Newsletter N°14

Scientific articles

18 Sep 2024

Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis

Clinical and Translational Science

Scientific articles

17 Sep 2024

Challenges and advancements in the development of vaccines and therapies against Chagas disease

The Lancet Microbe